Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 3, 2009, Pages 262-269

  Boga, Carla ^a   Fiume, Luigi ^a   Baglioni, Michele ^a   Bertucci, Carlo ^a   Farina, Claudio ^b   Kratz, Felix ^c   Manerba, Marcella ^a   Naldi, Marina ^a   Di Stefano, Giuseppina ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Kedrion Biopharmaceuticals ^*  (Italy)

^c TUMOR BIOLOGY CENTER   (Germany)

Author keywords

13C NMR spectroscopy of lactosaminated albumin conjugate of doxorubicin; Chemotherapy of hepatocellular carcinoma; Hepatocellular carcinoma targeted doxorubicin

Indexed keywords

(6 MALEIMIDOCAPROYL)HYDRAZONE DERIVATIVE; CYSTEINE; DOXORUBICIN; HUMAN ALBUMIN; HYDRAZONE DERIVATIVE; TRIS(2 CARBOXYETHYL)PHOSPHINE; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONJUGATION; CONTROLLED STUDY; DRUG STRUCTURE; HYDROLYSIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARBON ISOTOPES; DOXORUBICIN; GLYCOPROTEINS; HUMANS; HYDRAZONES; HYDROLYSIS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SERUM ALBUMIN;

EID: 70349211567     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.08.001     Document Type: Article

References (24)

1. Bendall M.R., Doddrell D.M., Pegg D.T., and Hull W.E. High resolution multipulse NMR spectra editing and DEPT (1982), Bruker Analytische Meβtechnik, Karlsruhe-Rheinstetten
2. Brewer C.F., and Riehm J.P. Evidence of possible non-specific reactions between N-ethylmaleimide and proteins. Anal. Biochem. 18 (1967) 248-255
3. 13C coupling constants in structural studies: XXXVII. Rotational conformations of hydroxy groups in pyranose, furanose, and septanose rings. Russ. J. Org. Chem. 40 (2004) 1194-1199 (references therein)
4. Di Stefano G., Busi C., Mattioli A., and Fiume L. Selective delivery to the liver of antiviral nucleoside analogs coupled to a high molecular mass lactosaminated poly-l-lysine and administered to mice by intramuscular route. Biochem. Pharmacol. 49 (1995) 1769-1775
5. Di Stefano G., Colonna F.P., Bongini A., Busi C., Mattioli A., and Fiume L. Ribavirin conjugated with lactosaminated poly-l-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatitis. Biochem. Pharmacol. 54 (1997) 357-363
6. Di Stefano G., Fiume L., Baglioni M., Busi C., Bolondi L., Farina C., Mori F., Chieco P., Pariali M., Kratz F., Molin L., Salmaso S., and Caliceti P. Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. Eur. J. Pharm. Sci. 33 (2008) 191-198
7. Di Stefano G., Kratz F., Lanza M., and Fiume F. Doxorubicin coupled to lactosaminated human albumin remains confined within mouse liver cells after the intracellular release from the carrier. Dig. Liver Dis. 35 (2003) 428-433
8. Di Stefano G., Lanza M., Kratz F., Merina L., and Fiume L. A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. Eur. J. Pharm. Sci. 23 (2004) 393-397
9. Enders D., Saint-Dizier A., Lannou M.I., and Lenzen A. The phospha-Michael addition in organic synthesis. Eur. J. Org. Chem. 1/2006 (2006) 29-49
10. Fiume L., Baglioni M., Bolondi L., Farina C., and Di Stefano G. Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. Drug Discovery Today 13 (2008) 1002-1009
11. Fiume L., Bonino F., Mattioli A., Chiaberghe E., Torrani Cerenzia M.R., Busi C., Brunetto M.R., and Verme G. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin. Lancet 2 (1988) 13-15
12. Fiume L., Busi C., Mattioli A., and Barbanti-Brodano G. Hepatocyte targeting of adenine-9-β-d-arabinofuranoside 5′-monophosphate (ara-AMP) coupled to lactosaminated albumin. FEBS Lett. 129 (1981) 261-264
13. Friebolin H. Basic One- and Two- Dimensional NMR Spectroscopy (1991), VCH, Weinheim pp.192-202
14. Greenfield R.S., Kaneko T., Daues A., Edson M.A., Fitzgerald K.A., Olech L.J., Grattan J.A., Spitalny G.L., and Braslawsky G.R. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker. Cancer Res. 50 (1990) 6600-6607
15. Gregory J.D. The stability of N-ethylmaleimide and its reaction with sulfhydryl groups. J. Am. Chem. Soc. 77 (1955) 3922-3923
16. Kalinowski H.-O., Berger S., and Braun S. Carbon-13 NMR spectroscopy (1988), John Wiley & Sons, Chichester
17. Kratz F., Warnecke A., Scheuermann K., Stockmar C., Schwab J., Lazar P., Drückes P., Esser N., Drevs J., Rognan D., Bissantz C., Hinderling C., Folkers G., Fichtner I., and Unger C. Probing of cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. J. Med. Chem. 45 (2002) 5523-5533
18. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall L.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
19. Schwartz B.A., and Gray G.R. Proteins containing reductively aminated disaccharides. Synthesis and chemical characterization. J. Biochem. Biophys. 181 (1977) 542-549
20. Shafer D.E., Inman J.K., and Lees A. Reaction of tris(2-carboxyethyl) phosphine (TCEP) with maleimide and α-haloacyl groups: anomalous elution of TCEP by gel filtration. Anal. Biochem. 282 (2000) 161-164
21. Smyth D.G., Nagamatsu A., and Fruton J.S. Some reactions of N-ethylmaleimide. J. Am. Chem. Soc. 82 (1960) 4600-4604
22. Torrani Cerenzia M.R., Fiume L., De Bernardi Venon W., Lavezzo B., Brunetto M.R., Ponzetto A., Di Stefano G., Busi C., Mattioli A., Gervasi G.B., Bonino F., and Verme G. Adenine arabinoside monophosphate coupled to lactosaminated albumin, administered for 4 weeks to patients with chronic type B hepatitis, decreased viremia without producing significant side effects. Hepatology 23 (1996) 657-661
23. Wilson G. Effect of reductive lactosamination on the hepatic uptake of bovine pancreatic ribonuclease A dimer. J. Biol. Chem. 253 (1978) 2070-2072
24. Zarski J.P., Barange K., Souvignet C., Bertini M., Marcellin P., Tran A., Deugnier Y., Couzigou P., Plages A., and Ambroise-Thomas P. Efficacy and safety of L-HSA-ara-AMP in chronic hepatitis B patients non responder to interferon therapy: a randomised clinical trial. J. Hepatol. 34 (2001) 487-488